FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test

Date : 12/05/2019 @ 6:10PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 41.2  -1.19 (-2.81%) @ 9:00PM
After Hours
Last Trade
Last $ 41.20 ◊ 0.00 (0.00%)

FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

2 Months : From Nov 2019 to Jan 2020

Click Here for more Roche Holding (QX) Charts.
   By Stephen Nakrosis 
 

The U.S. Food and Drug Administration said Thursday it authorized the marketing of Roche Molecular Systems Inc.'s diagnostic test to detect Methicillin-resistant Staphylococcus aureus, or MRSA, bacteria.

The FDA said the test "may allow health care professionals to evaluate patients for colonization with MRSA bacteria more quickly than traditional culture-based techniques."

The new test can detect the presence of MRSA from a nasal swab in as little as five hours, the FDA said, compared to the 24 to 48 hours a conventional diagnosis may take.

Roche Molecular Systems is part of Roche Holding AG.

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

December 05, 2019 12:55 ET (17:55 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.